Inventor · disambiguated record
Kazuo Kato
Also filed as: KATO KAZUO
26 granted patents·1 pending application·198 citations·filing 1979–2005
96Inventor score
Files withMOCHIDA PHARM CO LTD15JAPAN CHEM RES5NIPPON KAYAKU KK4MARUKO PHARMACEUTICAL CO2AJINOMOTO KK1
Top patents by PatentIndex Score
27 records- 0181US4334067AFlavan compounds and acid addition salts thereofMARUKO PHARMACEUTICAL CO·Filed 1980·Granted Jun 8, 1982·14 cites·8 claims
- 0273US4525465AWater-insoluble biospecific absorbent containing argininal derivativeNIPPON KAYAKU KK·Filed 1983·Granted Jun 25, 1985·22 cites·10 claims
- 0371US4994377AMethod for assaying 1,5-anhydroglucitol and kit thereforNIPPON KAYAKU KK·Filed 1987·Granted Feb 19, 1991·26 cites·10 claims
- 0465US5202339AHydantoin derivativesMOCHIDA PHARM CO LTD·Filed 1991·Granted Apr 13, 1993·9 cites·1 claims
- 0565US4810640AMethod of quantitative assay for 1,5-anhydroglucitolNIPPON KAYAKU KK·Filed 1986·Granted Mar 7, 1989·25 cites·7 claims
- 0664US6956046B24-hydroxypiperidine derivatives having analgesic activityMOCHIDA PHARM CO LTD·Filed 2002·Granted Oct 18, 2005·3 cites·10 claims
- 0762US5547945ARemitting agent for nephrotic syndrome and hepatopathy symptomsJAPAN CHEM RES·Filed 1994·Granted Aug 20, 1996·16 cites·7 claims
- 0859US4708944AProtease adsorbent and process for purifying TPA utilizing the sameNIPPON KAYAKU KK·Filed 1985·Granted Nov 24, 1987·10 cites·4 claims
- 0957US5004751AHydantoin derivativesMOCHIDA PHARM CO LTD·Filed 1989·Granted Apr 2, 1991·3 cites·8 claims
- 1051US5643920ATricyclic compound having anti-allergic activitiesMOCHIDA PHARM CO LTD·Filed 1993·Granted Jul 1, 1997·4 cites·11 claims
- 1150US4866055ACephalosporin derivatives and their crystalline derivativesMOCHIDA PHARM CO LTD·Filed 1987·Granted Sep 12, 1989·5 cites·13 claims
- 1247US5232936AHydantoin derivativesMOCHIDA PHARM CO LTD·Filed 1991·Granted Aug 3, 1993·2 cites·17 claims
- 1346US4839368A1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivativesMOCHIDA PHARM CO LTD·Filed 1987·Granted Jun 13, 1989·4 cites·38 claims
- 1446US4264497A1,5-Benzothiazepine compoundsMARUKO PHARMACEUTICAL CO·Filed 1979·Granted Apr 28, 1981·2 cites·4 claims
- 1544US5403731AProcess of producing modified superoxide dismutaseJAPAN CHEM RES·Filed 1993·Granted Apr 4, 1995·5 cites·9 claims
- 1644US5151431A4,5-dihydro-6H-imidazo[4,5,1-ij]quinolin-6-one-6-oxime-O-sulfonic acid derivatives useful for treating hypertension or edemaMOCHIDA PHARM CO LTD·Filed 1990·Granted Sep 29, 1992·7 cites·30 claims
- 1744US4968680A1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives, process for producing them and use thereofMOCHIDA PHARM CO LTD·Filed 1988·Granted Nov 6, 1990·4 cites·32 claims
- 1843US4880798ACephalosporin derivativesMOCHIDA PHARM CO LTD·Filed 1987·Granted Nov 14, 1989·5 cites·15 claims
- 1942US5750650AFibrinolytic protein and production method thereofJAPAN CHEM RES·Filed 1993·Granted May 12, 1998·7 cites·4 claims
- 2040US5296223ASubtilisin as an oral thrombolytic agentJAPAN CHEM RES·Filed 1992·Granted Mar 22, 1994·6 cites·6 claims
- 2139US5077410AIntermediate compounds of 1-acyl-2,3-dihydro-4(1h)-quinolinone-4-oxime derivativesMOCHIDA PHARM CO LTD·Filed 1989·Granted Dec 31, 1991·2 cites·15 claims
- 2239US2006004028A1Novel PARP inhibitorMOCHIDA PHARM CO LTD·Filed 2005·Application pending·0 cites
- 2338US5856334AImidazoquinoline derivativesMOCHIDA PHARM CO LTD·Filed 1994·Granted Jan 5, 1999·1 cites·10 claims
- 2437US5371196AProcess for producing secretory immunoglobulin A preparationsJAPAN CHEM RES·Filed 1993·Granted Dec 6, 1994·16 cites·10 claims
- 2535USRE35279EHydantoin derivativesMOCHIDA PHARM CO LTD·Filed 1994·Granted Jun 18, 1996·0 cites·2 claims
- 2630US4914099AHydantoin derivatives as aldose reductase inhibitorsMOCHIDA PHARM CO LTD·Filed 1988·Granted Apr 3, 1990·0 cites·8 claims
- 2727US5026842AProcess for preparing cephalosporin compoundsAJINOMOTO KK·Filed 1989·Granted Jun 25, 1991·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Kazuo Kato files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →